Home > Boards > US Listed > Medical - Drugs > NovaBay Pharmaceuticals, Inc. (NBY)

Holding and adding until we take off into

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
cash_cow1 Member Profile
 
Followed By 4
Posts 672
Boards Moderated 0
Alias Born 08/30/17
160x600 placeholder
NovaBay Pharmaceuticals Launches NovaWipes Eyelid Wipes on Amazon.com Business Wire - 12/2/2019 6:50:00 AM
NovaBay Pharmaceuticals Launches NovaSight™ Daily Vitamin for Ocular Health on Amazon.com Business Wire - 11/18/2019 6:50:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/7/2019 4:14:21 PM
NovaBay Pharmaceuticals Reports 2019 Third Quarter Financial Results Business Wire - 11/7/2019 4:05:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/6/2019 6:00:59 AM
NovaBay Pharmaceuticals Launches Online Sales of CelleRx® Skin Cleanser for Post-Aesthetic Dermatology & Cosmetic Surgery Pr... Business Wire - 11/4/2019 6:50:00 AM
NovaBay Pharmaceuticals to Hold Third Quarter 2019 Conference Call on November 7, 2019 Business Wire - 10/31/2019 6:50:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/30/2019 4:32:21 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 10/28/2019 4:31:11 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 10/28/2019 4:30:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:29:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:28:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:26:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:26:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:25:26 PM
NovaBay Pharmaceuticals to Distribute the NuLids System® for the Treatment of Dry Eye in Certain U.S. Geographies Business Wire - 10/28/2019 6:50:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 10/25/2019 4:33:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/10/2019 4:31:16 PM
NovaBay Pharmaceuticals Receives Approval for Distribution of Avenova in Australia Business Wire - 9/24/2019 6:50:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/16/2019 4:31:08 PM
NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors Business Wire - 9/16/2019 6:50:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/13/2019 8:31:28 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/13/2019 6:01:18 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/4/2019 4:33:03 PM
NovaBay Pharmaceuticals to Present at Two Investment Conferences in September Business Wire - 9/3/2019 6:50:00 AM
cash_cow1   Monday, 07/01/19 07:36:05 PM
Re: Earlofsandwich post# 830
Post # of 893 
Holding and adding until we take off into the double digits. The Earnings report will give us our next big share price boost, and Television commercials slots local and nationwide will give us our greatest boost of all for share price and Market cap biggest increase. Look what vicine eye drops did made billions. Avenova eye lid and lash spray a bacterial and debris removable spray around the eye lids and lashes is a patent ingredient treatment that can be use daily.

Plus the company is working on another drug from its pipeline. NovaBay is not going to stay a $2 stock for long, just like it didn't stay a penny stock for long. CEO Justin Hall and CFO Raleigh will get the job done. The ER will show big positive growth in sales revenue next month.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist